NasdaqCM - Delayed Quote USD
Synlogic, Inc. (SYBX)
At close: November 6 at 4:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,170.0000
3,371.0000
1,180.0000
1,754.0000
545.0000
Operating Expense
40,366.0000
58,532.0000
68,599.0000
62,519.0000
61,011.0000
Operating Income
-37,196.0000
-55,161.0000
-67,419.0000
-60,765.0000
-60,466.0000
Net Non Operating Interest Income Expense
2,171.0000
2,468.0000
1,265.0000
208.0000
1,296.0000
Other Income Expense
-21,129.0000
-4,575.0000
7.0000
-4.0000
-3.0000
Pretax Income
-56,154.0000
-57,268.0000
-66,147.0000
-60,561.0000
-59,173.0000
Tax Provision
10.0000
14.0000
--
--
--
Net Income Common Stockholders
-56,164.0000
-57,282.0000
-66,147.0000
-60,561.0000
-59,173.0000
Diluted NI Available to Com Stockholders
-56,164.0000
-57,282.0000
-66,147.0000
-60,561.0000
-59,173.0000
Basic EPS
-4.63
-8.81
-13.83
-16.35
-24.75
Diluted EPS
-4.63
-8.81
-13.83
-16.35
-24.75
Basic Average Shares
10,264.6080
6,502.2790
4,781.6960
3,688.6470
2,389.0490
Diluted Average Shares
10,264.6080
6,502.2790
4,781.6960
3,688.6470
2,389.0490
Total Operating Income as Reported
-61,690.0000
-55,161.0000
-67,419.0000
-60,765.0000
-60,466.0000
Total Expenses
40,366.0000
58,532.0000
68,599.0000
62,519.0000
61,011.0000
Net Income from Continuing & Discontinued Operation
-56,164.0000
-57,282.0000
-66,147.0000
-60,561.0000
-59,173.0000
Normalized Income
-39,875.7800
-54,076.1800
-66,147.0000
-60,561.0000
-59,173.0000
Interest Income
2,171.0000
2,469.0000
1,267.0000
210.0000
1,302.0000
Interest Expense
--
1.0000
2.0000
2.0000
6.0000
Net Interest Income
2,171.0000
2,468.0000
1,265.0000
208.0000
1,296.0000
EBIT
-56,154.0000
-57,267.0000
-66,145.0000
-60,559.0000
-59,167.0000
EBITDA
-54,955.0000
-55,309.0000
-63,625.0000
-58,116.0000
-56,531.0000
Reconciled Depreciation
1,199.0000
1,958.0000
2,520.0000
2,443.0000
2,636.0000
Net Income from Continuing Operation Net Minority Interest
-56,164.0000
-57,282.0000
-66,147.0000
-60,561.0000
-59,173.0000
Total Unusual Items Excluding Goodwill
-20,618.0000
-4,058.0000
--
--
--
Total Unusual Items
-20,618.0000
-4,058.0000
--
--
--
Normalized EBITDA
-34,337.0000
-51,251.0000
-63,625.0000
-58,116.0000
-56,531.0000
Tax Rate for Calcs
0.0002
0.0002
--
--
--
Tax Effect of Unusual Items
-4,329.7800
-852.1800
--
--
--
12/31/2020 - 9/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HLVX HilleVax, Inc.
1.9600
+3.70%
ACHL Achilles Therapeutics plc
1.0450
+0.97%
GLTO Galecto, Inc.
6.99
+1.90%
NERV Minerva Neurosciences, Inc.
2.3100
-2.12%
ALVR AlloVir, Inc.
1.0100
+2.03%
OKUR OnKure Therapeutics, Inc.
16.99
-3.52%
TBPH Theravance Biopharma, Inc.
8.71
+5.32%
ASMB Assembly Biosciences, Inc.
16.65
+0.54%
ANTX AN2 Therapeutics, Inc.
1.1000
+0.92%
SEER Seer, Inc.
2.0700
+1.97%